Skip to main content
Livermore
Livermore
ZHEN

Vantage Consulting Group Inc

SEC CIK
0001843547
Latest filing
Feb 11, 2026

ADCT holding history

ADC Therapeutics SA in every 13F filed by Vantage Consulting Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ADCT overviewAll 13F holders of ADCTFull Q4 2025 holdings

Shares (Q4 2025)
682,998
Value
$2.41M
% of portfolio
12.2%
Quarters held
20
Since Q1 2021
Holdings of ADCT by Vantage Consulting Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 2025682,998$2.41M12.2%00.0%UnchangedHolders
Q3 2025682,998$2.73M24.4%00.0%UnchangedHolders
Q2 2025682,998$1.83M31.9%−167,739−19.7%ReducedHolders
Q1 2025850,737$1.20M23.9%00.0%UnchangedHolders
Q4 2024850,737$1.69M16.1%00.0%UnchangedHolders
Q3 2024850,737$2.68M23.5%00.0%UnchangedHolders
Q2 2024850,737$2.69M2.0%00.0%UnchangedHolders
Q1 2024850,737$3.82M2.4%00.0%UnchangedHolders
Q4 2023850,737$1.41M0.9%00.0%UnchangedHolders
Q3 2023850,737$763.1K0.5%−34,783−3.9%ReducedHolders
Q2 2023885,520$1.90M1.1%−300,695−25.3%ReducedHolders
Q1 20231,186,215$2.31M1.3%00.0%UnchangedHolders
Q4 20221,186,215$4.56M2.7%00.0%UnchangedHolders
Q3 20221,186,215$5.72M3.3%00.0%UnchangedHolders
Q2 20221,186,215$9.43M5.3%−493,934−29.4%ReducedHolders
Q1 20221,680,149$24.7M9.6%00.0%UnchangedHolders
Q4 20211,680,149$33.9M9.1%00.0%UnchangedHolders
Q3 20211,680,149$45.6M9.8%00.0%UnchangedHolders
Q2 20211,680,149$40.9M7.1%00.0%UnchangedHolders
Q1 20211,680,149$41.0M8.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.